16:10 EDT PTC Therapeutics (PTCT) raises 2026 revenue view to $1.08B-$1.18B, consensus $990.78M
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- Tazeen Ahmad Reiterates Buy on Strengthened Votoplam Profile and Sephience Momentum; Keeps $93 Price Target Unchanged
- PTC Therapeutics Reports Positive 24-Month Votoplam Data
- PTC Therapeutics reports ‘positive’ results from PIVOT-HD study
- PTCT Earnings this Week: How Will it Perform?
- Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says